Cargando…

A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand

PURPOSE: Real-world data on maintenance treatment and prescription patterns provide insights into healthcare management among patients with chronic obstructive pulmonary disease (COPD), which benefits our understanding of current COPD treatment patterns in New Zealand. METHODS: We retrospectively an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiaomeng, Milea, Dominique, Navarro Rojas, Aldo Amador, Braganza, Anthony, Holbrook, Tim, Marett, Brett, Young, Robert, Scott, Raewyn J, Gribben, Barry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219234/ https://www.ncbi.nlm.nih.gov/pubmed/34177262 http://dx.doi.org/10.2147/COPD.S295183

Ejemplares similares

Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database
por: Milea, Dominique, et al.
Publicado: (2021)

Year-to-year trajectories of hospital utilisation rates among patients with COPD: a real-world, single-centre, retrospective cohort study
por: Yii, Anthony, et al.
Publicado: (2023)

Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea
por: Lee, Chang-Hoon, et al.
Publicado: (2022)

Characteristics of Patients with Chronic Obstructive Pulmonary Disease Treated with Long-Acting Bronchodilators in a Real-World Setting in Singapore: A Single-Center Observational Study
por: Sim, Marcus, et al.
Publicado: (2022)

Current appraisal of single inhaler triple therapy in COPD
por: Lipworth, Brian, et al.
Publicado: (2018)

Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
por: Kim, Sae Ahm, et al.
Publicado: (2016)

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
por: Bourbeau, Jean, et al.
Publicado: (2021)

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
por: Dobler, Claudia C.
Publicado: (2018)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
por: Naya, Ian, et al.
Publicado: (2018)

Erratum: Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
Publicado: (2016)

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
por: Resta, Emanuela, et al.
Publicado: (2022)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
por: Halpin, David M.G., et al.
Publicado: (2018)

Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
por: Fenwick, Elisabeth, et al.
Publicado: (2021)

Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial
por: Martin, Alan, et al.
Publicado: (2022)

Functional Benefit of Smoking Cessation and Triple Inhaler in Combustible Cigarette Smokers with Severe COPD: A Retrospective Study
por: Pezzuto, Aldo, et al.
Publicado: (2022)

Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2020)

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
por: Tabberer, Maggie, et al.
Publicado: (2020)

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
por: Ismaila, Afisi S, et al.
Publicado: (2019)

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
por: Halpin, David M.G., et al.
Publicado: (2021)

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
por: Kiff, Chris, et al.
Publicado: (2018)

Reforming primary health care: is New Zealand's primary health care strategy achieving its early goals?
por: Cumming, Jacqueline, et al.
Publicado: (2008)

Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England
por: Rothnie, Kieran J, et al.
Publicado: (2022)

Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
por: Paly, Victoria Federico, et al.
Publicado: (2022)

Characterization and burden of severe eosinophilic asthma in New Zealand: Results from the HealthStat Database
por: Shantakumar, Sumitra, et al.
Publicado: (2020)

Matching the Inhaler to the Patient in COPD
por: Peché, Rudi, et al.
Publicado: (2021)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
por: López-Campos, José Luis, et al.
Publicado: (2020)

Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
por: Suissa, Samy, et al.
Publicado: (2022)

Comparative efficacy of single-inhaler triple therapies for COPD: A protocol for systematic review and network meta-analysis
por: Jiang, Yixuan, et al.
Publicado: (2021)

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial
por: Halpin, David M G, et al.
Publicado: (2022)

PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
por: Criner, Gerard, et al.
Publicado: (2023)

Improving adherence with inhaler therapy in COPD
por: Lareau, Suzanne C, et al.
Publicado: (2010)

Safety and tolerability of inhalational anticholinergics in COPD
por: Sharafkhaneh, Amir, et al.
Publicado: (2013)

Single Inhaler LABA/LAMA for COPD
por: Malerba, Mario, et al.
Publicado: (2019)

Inhaled therapy reduces COPD mortality
por: Andreas, Stefan, et al.
Publicado: (2020)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Interleukin-6 and statin therapy: potential role in the management of COPD
por: Young, Robert P, et al.
Publicado: (2013)

When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals
por: Gaduzo, S, et al.
Publicado: (2019)

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
por: Magnussen, Helgo, et al.
Publicado: (2021)

Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study
por: Gessner, Christian, et al.
Publicado: (2022)

Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: A prospective observational study in China
por: Lin, Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e8p0fruh6v1kev6s498fg7vaak